LISINOPRIL
- Product NDC
- 42708-142
- 11-digit product format
- 427080142
- Labeler code
- 42708
- Product ID
- 42708-142_459bebab-b18e-58b4-e063-6294a90ad140
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- QPharma, Inc.
- Application
- ANDA076164
- Marketing category
- ANDA
- Marketing start
- 2011-11-01
- Substance
- LISINOPRIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LISINOPRIL
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LISINOPRIL | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | E7199S1YWR |
| Rxcui | 314077 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42708-142-30 | LISINOPRIL | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42708-142 | LISINOPRIL TABLET [QPHARMA, INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20241123_bd436b8b-98a6-584c-e053-2995a90ac15d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42708-142-30 | 42708014230 | 30 TABLET in 1 BOTTLE (42708-142-30) | 30 tablet | 2021-03-10 | 0000-00-00 | Yes | No | Current |